Announcements Trials

Browse Landscape

Phase

Status

Recruiting 4 Unknown 3 Withdrawn 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 51 Neoplasms 34 Colorectal Neoplasms 23 Lung Neoplasms 17 Prostatic Neoplasms 16 Melanoma 15 Neoplastic Cells, Circulating 13 Pancreatic Neoplasms 11 Multiple Myeloma 11 Uterine Cervical Neoplasms 10 Ovarian Neoplasms 10 Carcinoma, Non-Small-Cell Lung 8 Papillomavirus Infections 7 Neoplasm Metastasis 7 Leukemia, Myeloid, Acute 7 Colonic Neoplasms 7 Lymphoma, Follicular 6 Lymphoma 6 Hematologic Neoplasms 6 Uveal Melanoma 5 Sarcoma 5 Head and Neck Neoplasms 5 Glioma 5 Uterine Cervical Dysplasia 4 Urinary Bladder Neoplasms 4 Rectal Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Glioblastoma 4 Disease 4 COVID-19 4

Interventions

Cisplatin 117 Oxaliplatin 111 Fluorouracil 100 Capecitabine 90 Docetaxel 69 Leucovorin 60 Irinotecan 57 Paclitaxel 49 S 1 (combination) 38 pembrolizumab 35 Trastuzumab 31 Radiotherapy 25 Bevacizumab 20 Nivolumab 19 Epirubicin 19 titanium silicide 18 Surgical Procedures, Operative 17 Carboplatin 17 Ramucirumab 16 Cetuximab 15 Gastrectomy 13 apatinib 12 Everolimus 12 Gemcitabine 11 Albumin-Bound Paclitaxel 10 Neoadjuvant Therapy 8 Folfox protocol 8 Drug Therapy 8 Chemotherapy, Adjuvant 8 Radiation 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Stomach Neoplasms × Blood Specimen Collection × Clear all

NCT04253106 2024-09-23

LISA-HDGC

Assistance Publique - Hôpitaux de Paris

Phase NA Completed

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡